Join top industry minds in small-group sessions tackling key challenges and opportunities in advanced therapies.
At Advanced Therapies Europe 2025, networking goes beyond the surface. Our curated workshops bring together a select group of industry leaders, innovators, and decision-makers to discuss the topics that matter most — from scaling biomanufacturing and commercial strategy to IP, funding, regulatory clarity, and team building.
Please register your interest in our exclusive workshop lineup
How innovation has now shifted from technology to Biology and biology platforms, further addressing market, clinical, and safety needs. Impact and consequences from a regulatory perspective.
Speakers
Emmanuel Cameau, Scientific Director, Viral Vectors - Cytiva
Anna Malinowska, Lead Regulatory Strategist - Cytiva
Register your interest
AAV remains the dominant viral vector in gene therapy, with funding favouring de-risked programs. Early focus on manufacturing spanning supply chain, scalability, analytics, timelines, compliance, and make-vs-buy decisions, minimises risk and accelerates progress to commercial scale.
Speakers
Philip Wills, CCO - Catalent
Register your interest
A Case Study and Panel Discussion featuring ADVA X3 from Adva Biotechnology, and Autolomate from Autolomous.
Speakers
Alexander Seyf, CEO & Co-founder, Autolomous
Register your interest
Want a preview of the ATE community?
See who was in the room this year and the organisations leading the way in advanced therapies.
Download the 2025 Attendee List
)
)
)
)
)
)
)
)
)
)
